Healthy Clinical Trial
Official title:
Determination of Reference Values for Sublingual Microcirculation in Healthy Volunteers in the Pediatric Population Using the Sidestream Dark-Field Imaging Method
| NCT number | NCT05324228 |
| Other study ID # | 300/7 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | December 3, 2021 |
| Est. completion date | September 16, 2022 |
| Verified date | April 2023 |
| Source | Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The main goal of the study is to determine the physiological parameters of sublingual microcirculation in children in different age categories using Sidestream Dark-Field Imaging Method. No significant differences are expected to be found between measurements in healthy volunteers in different age categories.
| Status | Completed |
| Enrollment | 40 |
| Est. completion date | September 16, 2022 |
| Est. primary completion date | September 16, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 3 Years to 18 Years |
| Eligibility | Inclusion Criteria: - healthy child - informed consent of parents Exclusion Criteria: - inability to cooperate - acute illness - chronic illness - chronic medication - substance abuse |
| Country | Name | City | State |
|---|---|---|---|
| Czechia | Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. | Ústí Nad Labem |
| Lead Sponsor | Collaborator |
|---|---|
| Vlasta Krausová |
Czechia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Determination of Total Vascular Density of sublingual microcirculation of children | Total length of vessels divided by total surface of area | baseline | |
| Primary | Determination of Microvascular Flow Index (MFI) of sublingual microcirculation of children | The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant. The MFI score represents the averaged values of the four. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). | baseline | |
| Primary | Determination of Small Vessel Density of sublingual microcirculation of children | Total length of small vessels divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). | baseline | |
| Primary | Determination of Proportion of Perfused Vessels (all) of sublingual microcirculation of children | The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels. | baseline | |
| Primary | Determination of Proportion of Perfused Small Vessels (PPV) of sublingual microcirculation of children | The proportion of perfused small vessels (PPV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels.
A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). |
baseline | |
| Primary | Determination of Perfused Vessel Density (all) of sublingual microcirculation of children | Total length of vessels - (no flow + intermittent flow) divided by total surface of area | baseline | |
| Primary | Determination of Perfused Small Vessel Density (PVD) of sublingual microcirculation of children | Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). | baseline | |
| Primary | Determination of DeBacker Score of sublingual microcirculation of children | In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen. Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines. | baseline | |
| Secondary | Differences in Total Vascular Density in children of different age categories | Total length of vessels divided by total surface of area. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline | |
| Secondary | Differences in Microvascular Flow Index (MFI) in children of different age categories | The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant. The MFI score represents the averaged values of the four. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline | |
| Secondary | Differences in Small Vessel Density in children of different age categories | Total length of small vessels divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline | |
| Secondary | Differences in Proportion of Perfused Vessels (all) in children of different age categories | The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline | |
| Secondary | Differences in Perfused Vessel Density (all) in children of different age categories | Total length of vessels - (no flow + intermittent flow) divided by total surface of area. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline | |
| Secondary | Differences in Proportion of Perfused Small Vessels (PPV) in children of different age categories | The proportion of perfused small vessels (PPV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels.
A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. |
baseline | |
| Secondary | Differences in Perfused Small Vessel Density (PVD) in children of different age categories | Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline | |
| Secondary | Differences in DeBacker Score in children of different age categories | In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen. Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. | baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |